Blue Owl Capital (OWL) Prices 26.7M Share Secondary Offering at $14.50/sh

Go back to Blue Owl Capital (OWL) Prices 26.7M Share Secondary Offering at $14.50/sh

After-Hours Stock Movers 12/06: (ACAD) (MDB) (DWAC) Higher; (HQY) (OWL) (SI) Lower (more...)

December 6, 2021 5:27 PM EST

After-Hous Stock Movers

HealthEquity (NASDAQ: HQY) 26% LOWER; reported Q3 EPS of $0.35, in-line with the analyst estimate of $0.35. Revenue for the quarter came in at $180 million versus the consensus estimate of $185.05 million. HealthEquity sees FY2022 EPS of $1.30-$1.35, versus the consensus of $1.48. HealthEquity sees FY2022 revenue of $750-755 million, versus the consensus of $762.3 million.

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) 23.8% HIGHER; announced positive top-line results from the pivotal, Phase 3 Lavender study evaluating the efficacy and safety of trofinetide in 187 girls and young... More

Blue Owl Capital (OWL) Launches Secondary 26.7M Share Offering

December 6, 2021 4:39 PM EST

Blue Owl Capital Inc. (NYSE: OWL) announced today that NBSH Blue Investments II, LLC, intends to offer in an underwritten public offering 26,717,377 shares of the Company's Class A common stock. The Offering consists entirely of secondary shares to be sold by the Selling Stockholder. The Company will not receive any of the proceeds from the shares sold in the Offering.

Goldman Sachs & Co. LLC, BofA Securities, Inc. and J.P. Morgan Securities LLC are acting as joint bookrunning managers for the Offering.

A... More

Oppenheimer Starts Blue Owl Capital (OWL) at Perform

December 6, 2021 4:09 PM EST

Oppenheimer analyst Chris Kotowski initiates coverage on Blue Owl Capital (NYSE: OWL) with a Perform rating.


For an analyst ratings summary and ratings history on Blue Owl Capital click here. For more ratings news on Blue Owl Capital click here.


Shares of Blue Owl Capital closed at $15.08 yesterday.

... More